Iveda Solutions, Inc. IVDA 深 滬
等待開盤 09-05 09:30:00 美东时间
1.47
-0.030
-2.00%
華盛通- 最 高1.49
- 今 開1.48
- 成交量 3.37万股
- 最 低 1.45
- 昨 收 1.50
- 總市值 412.79万
- 52周最高 8.05
- 市盈率 靜 --
- 換手率 1.20%
- 52周最低 1.27
- 委 比 -26.79%
- 總股本 280.81万
- 歷史最高 38.96
- 量 比 0.47
- 振 幅 2.67%
- 歷史最低 1.42
- 每 手 1
- 風險率 1.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多再鼎医药：维替索妥尤单抗在香港获批用于治疗复发性或转移性宫颈癌
9月2日，再鼎医药宣布，香港特别行政区政府卫生署已批准TIVDAK®（维替索妥尤单抗）在香港地区用于治疗化疗期间或之后出现疾病进展的复发性或转移性宫颈癌成年患者...
09-02 08:33
Iveda Solutions Approves New Stock Purchase Warrants
An update from Iveda Solutions ( ($IVDA) ) is now available. On August 29, 2025...
08-30 05:34
12 Information Technology Stocks Moving In Friday's Intraday Session
Gainers HeartCore Enterprises (NASDAQ:HTCR) shares rose 28.0% to $0.79 during ...
08-23 01:06
Iveda Solutions Q2 EPS $(0.20) Up From $(0.24) YoY, Sales $1.528M Down From $1.534M YoY
Iveda Solutions (NASDAQ:IVDA) reported quarterly losses of $(0.20) per share. This is a 16.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported $1.528 million in
08-15 04:20
百济盈利，再鼎环比翻倍，信达收入52亿，股价却齐跌？创新七君进入重估时刻
对于以“创新七君”为代表的中国头部Biotech来说，已在2024年年报披露时普遍站上盈亏平衡线，2025年则不再是验证能否盈利的一年，而是走进拐点的新周期...
08-13 21:59
Iveda Solutions Granted Nasdaq Compliance Extension
Iveda Solutions ( ($IVDA) ) has issued an update. On July 23, 2025, Iveda Solut...
07-31 05:54
Iveda Solutions Adjourns Stockholder Meeting for Proposal Vote
The latest update is out from Iveda Solutions ( ($IVDA) ). On June 2, 2025, Ive...
06-07 05:18
Iveda Solutions Q1 GAAP EPS $(0.28) Up From $(0.64) YoY, Sales $1.48M Up From $346.77K YoY
Iveda Solutions (NASDAQ:IVDA) reported quarterly losses of $(0.28) per share. This is a 56.25 percent increase over losses of $(0.64) per share from the same period last year. The company reported $1.48 million in sales
05-14 05:54
